Upcoming events

Late-breaking trials and trial updates in coronary interventions

Session comprising selected EuroPCR 2016 late-breaking trial submissions

Chairpersons: T. Cuisset, J.F. Tanguay

Presentations available when logged in:

  • The balance of thrombosis and bleeding in patients at high-bleeding risk from LEADERS FREE trial
  • Six-month vs. twelve-month DAPT following long-length everolimus-eluting stent implantation
  • Randomised, double-blinded, placebo-controlled trial of intramyocardial autologous bone marrow CD133+ cells on left ventricle perfusion and functio...
  • The final five-year results from the COMPARE II trial: the first real long-term results between biodegradable polymer biolimus-eluting stent and du...
  • Five-year non-enrolled TWENTE: clinical outcome of participants in the randomised TWENTE trial vs. non-enrolled eligible patients, treated with the...
  • Three-year clinical follow-up of the RIBS V randomised clinical trial
  • A randomised control trial comparing two DES on the degree of early stent healing and late neointima progression using longitudinal sequential OCT...